发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 352 |
| England | 67 |
| Switzerland | 28 |
| Netherlands | 25 |
| France | 23 |
| Sweden | 23 |
| GERMANY (FED REP GER) | 22 |
| Canada | 20 |
| Australia | 10 |
| Belgium | 10 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| PFIZER | 41 |
| STATE UNIVERSITY OF NEW YORK (SUNY) SYS... | 35 |
| MERCK & COMPANY | 32 |
| GLAXOSMITHKLINE | 20 |
| NOVARTIS | 18 |
| US FOOD & DRUG ADMINISTRATION (FDA) | 18 |
| ASTRAZENECA | 17 |
| CERTARA STRATEG CONSULTING | 17 |
| ROCHE HOLDING | 17 |
| ASTELLAS PHARMACEUTICALS | 15 |
文章引用情况
1
Population pharmacokinetics and exposure-response modeling and simulation for evolocumab in healthy volunteers and patients with hypercholesterolemia2
Model reduction in mathematical pharmacology3
Projected 24-hour post-dose ocular itching scores post-treatment with olopatadine 0.7% versus 0.2%4
Population pharmacokinetic reanalysis of a Diazepam PBPK model: a comparison of Stan and GNU MCSim5
Population pharmacokinetics of inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma6
Development of visual predictive checks accounting for multimodal parameter distributions in mixture models7
Population pharmacokinetics and pharmacodynamics of piperacillin in critically ill patients during the early phase of sepsis8
Guiding dose selection of monoclonal antibodies using a new parameter (AFTIR) for characterizing ligand binding systems9
A distributed delay approach for modeling delayed outcomes in pharmacokinetics and pharmacodynamics studies10
Establishing in vitro-in vivo correlation for antibody drug conjugate efficacy: a PK/PD modeling approach